Similar articles

• Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.

  Sobel BE. Sobel BE. Coron Artery Dis. 2010 May;21(3):189-98. doi: 10.1097/MCA.0b013e3283383ebe. Coron Artery Dis. 2010. PMID: 20308880 Review.
• Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.

  Magee MF, Isley WL; BARI 2D Trial Investigators. Magee MF, et al. Am J Cardiol. 2006 Jun 19;97(12A):20G-30G. doi: 10.1016/j.amjcard.2006.02.024. Epub 2006 Apr 19. Am J Cardiol. 2006. PMID: 16813735
• The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease.

  Rutter MK, Nesto RW. Rutter MK, et al. Diab Vasc Dis Res. 2010 Jan;7(1):69-72. doi: 10.1177/1479164109354145. Diab Vasc Dis Res. 2010. PMID: 20368235
• Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

  Anselmino M, Malmberg K, Ohrvik J, Rydén L; Euro Heart Survey Investigators. Anselmino M, et al. Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23. doi: 10.1097/HJR.0b013e3282f335d0. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18391651
• [Differentiated treatment of diabetics with an acute coronary syndrome].

  Hamm CW, Hamann A. Hamm CW, et al. Dtsch Med Wochenschr. 2006 Nov 24;131(47 Suppl 7):S208-10. doi: 10.1055/s-2006-956262. Dtsch Med Wochenschr. 2006. PMID: 17109250 Review. German. No abstract available.